Serum Müllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer

BACKGROUND: In preclinical studies, müllerian inhibiting substance (MIS) has a protective affect against breast cancer. Our objective was to determine whether serum MIS concentrations were associated with cancerous or precancerous lesions. Blood from 30 premenopausal women was collected and serum ex...

Descripción completa

Detalles Bibliográficos
Autores principales: McCoy, Andrew C, Kliethermes, Beth, Zhang, Ke, Qin, Wenyi, Sticca, Robert, Bouton, Michael, Sauter, Edward R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130667/
https://www.ncbi.nlm.nih.gov/pubmed/21615907
http://dx.doi.org/10.1186/1756-0500-4-152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130667/
https://www.ncbi.nlm.nih.gov/pubmed/21615907
http://dx.doi.org/10.1186/1756-0500-4-152

Ejemplares similares